Self‐Assembled Ruthenium Complexes With Sonobleaching Ligand for Enhanced Tumor Penetration and Immunogenic Sonotherapy
Advanced Materials · 2026-03 · 38 (13)
DOI: 10.1002/adma.202523608 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 24.01.2026. Verfasst von Maomao He und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Fine Chemicals, Frontiers Science Center For Smart Materials Oriented Chemical Engineering, Dalian University of Technology, …. Hauptthemen laut MEDLINE: Ruthenium, Ultrasonic Therapy, Antineoplastic Agents, Coordination Complexes. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 70 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Liaoning Province, Liaoning Binhai Laboratory.
Abstract (Originalsprache)
Ruthenium complexes, which can be activated with precise light‐induced spatiotemporal control, are recognized as promising candidates for cancer therapy. However, the inadequate tumor penetration and their dependence on light activation present challenges to deeper clinical application. Herein, we introduce a charge‐reversal strategy to enhance tumor penetration and cellular uptake of RuIR783, a self‐assembled metalloprodrug activated by ultrasound, thereby enabling deep tissue penetration. RuIR783 is synthesized by coordinating a Ru(II) polypyridyl complex with a heptamethine cyanine dye bearing two hydrophilic sulfonic groups. The cyanine dye component serves as both the ultrasound antenna and the self‐assembly motif. RuIR783 self‐assembles into large nanoparticles with negatively charged surfaces, facilitating their circulation in the bloodstream and accumulation at tumor sites. Upon ultrasound irradiation, the cyanine scaffold within the accumulated RuIR783 nanoparticles undergoes rapid sonobleaching, resulting in their transformation into smaller nanofragments with cationic surface charges. This transformation enhanced tumor penetration by 6.5‐fold and cellular internalization by 4.2‐fold. The generation of singlet oxygen and monocationic anticancer Ru complexes enhances the efficacy of immunogenic cell death through mitochondrial damage, achieving a 90.5% tumor inhibition rate. This study demonstrates the first ultrasound‐mediated activation of metalloprodrugs for immunogenic tumor treatment through morphological transformation and charge reversal.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Fine Chemicals, Frontiers Science Center For Smart Materials Oriented Chemical Engineering, Dalian University of Technology, Dalian, China.
- Ningbo Institute of Dalian University of Technology, Ningbo, China.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Liaoning Province
- Liaoning Binhai Laboratory
- Project of Xingliao Talents Program of Liaoning Province
- Liaoning Province Science and Technology Plan Joint Program
- China Postdoctoral Science Foundation
- Dalian Youth Science and Technology Star
- Fundamental Research Funds for the Central Universities
Zitieren
APA
He, M., Cheng, X., Zhang, L., Zhang, Z., Liu, C., Zeng, X., Ma, Z., Fan, J., Peng, X., & Sun, W. (2026). Self‐Assembled Ruthenium Complexes With Sonobleaching Ligand for Enhanced Tumor Penetration and Immunogenic Sonotherapy. Advanced Materials, 38(13). https://doi.org/10.1002/adma.202523608
Vancouver
He M, Cheng X, Zhang L, Zhang Z, Liu C, Zeng X, et al. Self‐Assembled Ruthenium Complexes With Sonobleaching Ligand for Enhanced Tumor Penetration and Immunogenic Sonotherapy. Advanced Materials. 2026;38(13). doi:10.1002/adma.202523608
BibTeX
@article{He2026,
author = {He, Maomao and Cheng, Xitong and Zhang, Linhao and Zhang, Zongwei and Liu, Chaogan and Zeng, Xiaolong and Ma, Zhiyuan and Fan, Jiangli and Peng, Xiaojun and Sun, Wen},
title = {Self‐Assembled Ruthenium Complexes With Sonobleaching Ligand for Enhanced Tumor Penetration and Immunogenic Sonotherapy},
journal = {Advanced Materials},
year = {2026},
volume = {38},
number = {13},
doi = {10.1002/adma.202523608}
}
EUVIMED